FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994828013> ?p ?o ?g. }

• W1994828013 endingPage "44" @default.
• W1994828013 startingPage "39" @default.
• W1994828013 abstract "Synthetic pyrethroids are one of the most frequently and widely used class of insecticides, primarily because they have a higher insect to mammalian toxicity ratio than organochlorines or organophosphates. The basic structure of pyrethroids can be characterized as an acid joined to an alcohol by an ester bond. Pyrethroid degradation occurs through either oxidation at one or more sites located in the alcohol or acid moieties or hydrolysis at the central ester bond, the latter reaction being important for mammalian metabolism of most pyrethroids. The primary alcohol liberated from the ester cleavage is hydroxylated to 3-phenoxybenzyl alcohol, which for most pyrethroids is then oxidized to 3-phenoxybenzoic acid. These products may then be conjugated with amino acids, sulfates, sugars, or sugar acids. In vitro studies have suggested that some of the pyrethroids may have estrogenic activity. Interestingly, the chemical structure of specific pyrethroid metabolites indicates that they may be more likely to interact with the estrogen receptor than the parent compounds. Two of the pyrethroid metabolites, 3-phenoxybenzoic acid (3PBA) and 3-phenoxybenzyl alcohol (3PBalc) have been reported to have endocrine activity using a yeast based assay. 3PBAlc exhibited estrogenic activity with reported EC(50)s of 6.67 x 10(-6) and 2 x 10(-5) while 3PBAcid exhibited anti-estrogenic activity with a calculated IC(50) of 6.5 x 10(-5). To determine if the metabolites were able to cause the same effects in a mammalian system, the estrogen-dependent cell line, MCF-7, was utilized. Cells were treated with 1.0, 10.0 or 100.0 microM concentrations of each metabolite and cytotoxicity was assessed. The two lowest concentrations of both metabolites did not induce cell death and even appeared to increase proliferation over that of the control cells. However, when cellular proliferation was measured using a Coulter counter neither metabolite stimulated proliferation (1.0 nM, 10.0 nM, or 10.0 microM) or induced an estrogen receptor alpha/ERE-controlled luciferase reporter in the MCF-7 cells. Following the in vitro screenings, the metabolites were then evaluated for estrogenic activity in vivo using the uterotrophic assay in Sprague-Dawley rats. Animals were orally gavaged (10.0, 5.0, and 1.0 mg/kg) once daily for 3 days. Neither metabolite had any effect on uterine wet weight, body weight, or organ weight. Lastly, in order to determine if either metabolite was able to alter the onset of puberty, immature female rats were orally gavaged (10.0, 5.0, and 1.0 mg/kg) once a day with the metabolites beginning 1 day post-weaning until the onset of puberty as evidenced by vaginal opening (VO). Again, neither metabolite had any effect on the onset of VO." @default.
• W1994828013 created "2016-06-24" @default.
• W1994828013 creator A5034156484 @default.
• W1994828013 creator A5042022693 @default.
• W1994828013 creator A5085569647 @default.
• W1994828013 date "2010-01-01" @default.
• W1994828013 modified "2023-09-25" @default.
• W1994828013 title "The pyrethroid metabolites 3-phenoxybenzoic acid and 3-phenoxybenzyl alcohol do not exhibit estrogenic activity in the MCF-7 human breast carcinoma cell line or Sprague–Dawley rats" @default.
• W1994828013 cites W1604011158 @default.
• W1994828013 cites W1965192117 @default.
• W1994828013 cites W1983250252 @default.
• W1994828013 cites W1999956201 @default.
• W1994828013 cites W2006112787 @default.
• W1994828013 cites W2007125072 @default.
• W1994828013 cites W2009254035 @default.
• W1994828013 cites W2023704290 @default.
• W1994828013 cites W2025605433 @default.
• W1994828013 cites W2026849735 @default.
• W1994828013 cites W2035115924 @default.
• W1994828013 cites W2044773366 @default.
• W1994828013 cites W2046401222 @default.
• W1994828013 cites W2050942092 @default.
• W1994828013 cites W2051422473 @default.
• W1994828013 cites W2055878543 @default.
• W1994828013 cites W2063832436 @default.
• W1994828013 cites W2069293677 @default.
• W1994828013 cites W2071262171 @default.
• W1994828013 cites W2071820123 @default.
• W1994828013 cites W2075869676 @default.
• W1994828013 cites W2076342437 @default.
• W1994828013 cites W2112943607 @default.
• W1994828013 cites W2124174369 @default.
• W1994828013 cites W2128067173 @default.
• W1994828013 cites W2162603825 @default.
• W1994828013 doi "https://doi.org/10.1016/j.tox.2009.10.003" @default.
• W1994828013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19853000" @default.
• W1994828013 hasPublicationYear "2010" @default.
• W1994828013 type Work @default.
• W1994828013 sameAs 1994828013 @default.
• W1994828013 citedByCount "52" @default.
• W1994828013 countsByYear W19948280132012 @default.
• W1994828013 countsByYear W19948280132013 @default.
• W1994828013 countsByYear W19948280132014 @default.
• W1994828013 countsByYear W19948280132015 @default.
• W1994828013 countsByYear W19948280132016 @default.
• W1994828013 countsByYear W19948280132017 @default.
• W1994828013 countsByYear W19948280132018 @default.
• W1994828013 countsByYear W19948280132020 @default.
• W1994828013 countsByYear W19948280132021 @default.
• W1994828013 countsByYear W19948280132022 @default.
• W1994828013 crossrefType "journal-article" @default.
• W1994828013 hasAuthorship W1994828013A5034156484 @default.
• W1994828013 hasAuthorship W1994828013A5042022693 @default.
• W1994828013 hasAuthorship W1994828013A5085569647 @default.
• W1994828013 hasConcept C121608353 @default.
• W1994828013 hasConcept C161176658 @default.
• W1994828013 hasConcept C185592680 @default.
• W1994828013 hasConcept C2776035571 @default.
• W1994828013 hasConcept C2777477808 @default.
• W1994828013 hasConcept C2781066024 @default.
• W1994828013 hasConcept C515207424 @default.
• W1994828013 hasConcept C530470458 @default.
• W1994828013 hasConcept C54355233 @default.
• W1994828013 hasConcept C55493867 @default.
• W1994828013 hasConcept C62231903 @default.
• W1994828013 hasConcept C6557445 @default.
• W1994828013 hasConcept C84606932 @default.
• W1994828013 hasConcept C86803240 @default.
• W1994828013 hasConceptScore W1994828013C121608353 @default.
• W1994828013 hasConceptScore W1994828013C161176658 @default.
• W1994828013 hasConceptScore W1994828013C185592680 @default.
• W1994828013 hasConceptScore W1994828013C2776035571 @default.
• W1994828013 hasConceptScore W1994828013C2777477808 @default.
• W1994828013 hasConceptScore W1994828013C2781066024 @default.
• W1994828013 hasConceptScore W1994828013C515207424 @default.
• W1994828013 hasConceptScore W1994828013C530470458 @default.
• W1994828013 hasConceptScore W1994828013C54355233 @default.
• W1994828013 hasConceptScore W1994828013C55493867 @default.
• W1994828013 hasConceptScore W1994828013C62231903 @default.
• W1994828013 hasConceptScore W1994828013C6557445 @default.
• W1994828013 hasConceptScore W1994828013C84606932 @default.
• W1994828013 hasConceptScore W1994828013C86803240 @default.
• W1994828013 hasIssue "1-3" @default.
• W1994828013 hasLocation W19948280131 @default.
• W1994828013 hasLocation W19948280132 @default.
• W1994828013 hasOpenAccess W1994828013 @default.
• W1994828013 hasPrimaryLocation W19948280131 @default.
• W1994828013 hasRelatedWork W1642498015 @default.
• W1994828013 hasRelatedWork W1927591950 @default.
• W1994828013 hasRelatedWork W2026586334 @default.
• W1994828013 hasRelatedWork W2052493351 @default.
• W1994828013 hasRelatedWork W2059989893 @default.
• W1994828013 hasRelatedWork W2123346024 @default.
• W1994828013 hasRelatedWork W2169413406 @default.
• W1994828013 hasRelatedWork W2398235709 @default.
• W1994828013 hasRelatedWork W4379618501 @default.
• W1994828013 hasRelatedWork W21435082 @default.
• W1994828013 hasVolume "267" @default.

• next